Picture of Liminal BioSciences logo

LMNL — Liminal BioSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Liminal BioSciences Reports Third Quarter Financial Results

Nov 12 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES REPORTS THIRD QUARTER FINANCIAL
RESULTS
    * LIMINAL BIOSCIENCES - KENNETH GALBRAITH TENDERED
RESIGNATION AS
CEO AND AS MEMBER OF BOARD FOR PERSONAL REASONS, EFFECTIVE NOV.
13
    * LIMINAL BIOSCIENCES - BRUCE PRITCHARD & PATRICK SARTORE
HAVE
AGREED TO ACT IN CAPACITY OF CEO & PRESIDENT, RESPECTIVELY
    * LIMINAL BIOSCIENCES INC - GALBRAITH WILL BE INVOLVED IN
TRANSITION OF CEO DUTIES TO MR. PRITCHARD
    * LIMINAL BIOSCIENCES INC - NET LOSS FROM CONTINUING
OPERATIONS
WAS $23.3 MILLION FOR Q3 OF 2020 COMPARED TO $29.6 MILLION

Source text for Eikon:  ID:nCNWZ9hXRa 
Further company coverage:  LMNL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Liminal BioSciences

See all news